Cargando…
Correction: Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
Autores principales: | Bartlett, Thomas E., Evans, Iona, Jones, Allison, Barrett, James E., Haran, Shaun, Reisel, Daniel, Papaikonomou, Kiriaki, Jones, Louise, Herzog, Chiara, Pashayan, Nora, Simões, Bruno M., Clarke, Robert B., Evans, D. Gareth, Ghezelayagh, Talayeh S., Ponandai-Srinivasan, Sakthivignesh, Boggavarapu, Nageswara R., Lalitkumar, Parameswaran G., Howell, Sacha J., Risques, Rosa Ana, Rådestad, Angelique Flöter, Dubeau, Louis, Gemzell-Danielsson, Kristina, Widschwendter, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295457/ https://www.ncbi.nlm.nih.gov/pubmed/35854342 http://dx.doi.org/10.1186/s13073-022-01086-y |
Ejemplares similares
-
Antiprogestins reduce epigenetic field cancerization in breast tissue of young healthy women
por: Bartlett, Thomas E., et al.
Publicado: (2022) -
DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment
por: Herzog, Chiara, et al.
Publicado: (2023) -
Bromocriptine inhibits proliferation in the endometrium from women with adenomyosis
por: Tang, Yiqun, et al.
Publicado: (2023) -
Compartmentalized gene expression profiling of receptive endometrium reveals progesterone regulated ENPP3 is differentially expressed and secreted in glycosylated form
por: Boggavarapu, Nageswara Rao, et al.
Publicado: (2016) -
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples
por: Barrett, James E., et al.
Publicado: (2022)